Sigilon Therapeutics is a Cambridge, Massachusetts-based biotechnology company founded by Omid Veiseh.
Sigilon Therapeutics focuses on therapeutics and develops functional cures for patients with a wide range of chronic diseases. Its Shielded Living Therapeutics platform combines advanced cell engineering with innovations in biocompatible materials.
Sigilon Therapeutics is a Cambridge, Massachusetts-based biotechnology company founded by Omid Veiseh.